Evoprenine



Compound IDCDAMM02604
Common nameEvoprenine
IUPAC name1-hydroxy-2-methoxy-10-methyl-3-(3-methylbut-2-enoxy)acridin-9-one
Molecular formulaC20H21NO4

Experimental data

Retention time6.06
Adduct[M+H]+
Actual mz340.156
Theoretical mz340.154
Error6.24
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3599

Identifiers and class information

Inchi keySKJRDJBAXQXFJY-UHFFFAOYSA-N
SmilesO=C1C=2C=CC=CC2N(C3=CC(OCC=C(C)C)=C(OC)C(O)=C13)C
SuperclassOrganoheterocyclic compounds
ClassQuinolines and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)339.39
Computed dipole moment(dipole)7.429
Total solvent accessible surface area (SASA)631.652
Hydrophobic component of SASA (FOSA)350.53
Hydrophilic component of SASA (FISA)78.246
Pie component of the SASA (PISA)202.876
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1112.07
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)3.75
Free energy of solvation of dipole (dip^2/V)0.049626
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.821816
Predicted polarizability in cubic angstroms (QPpolrz)37.078
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.513
Predicted octanol/gas partition coefficient (QPlogPoct)14.488
Predicted water/gas partition coefficient (QPlogPw)5.742
Predicted octanol/water partition coefficient (QPlogPo/w)4.42
Predicted aqueous solubility (QPlogS)-5.41
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.38
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.383
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1794.28
Predicted brain/blood partition coefficient (QPlogBB)-0.51
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)930.628
Predicted skin permeability, log Kp (QPlogKp)-1.767
PM3 calculated ionization potential (IP(ev))8.305
PM3 calculated electron affinity (EA(eV))0.443
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.631
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)63.991
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29274ADORA2AAdenosine A2a receptorT77365SwissTargetPrediction
O00206TLR4Toll-like receptor 4 (by homology)T81443SEA
Q15746MYLKMyosin light chain kinase, smooth muscleT97141SEA
P55786NPEPPSPuromycin-sensitive aminopeptidaseT15610SEA
O60911CTSVCathepsin (V and K)T93653SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q9UJ67APAF1Caterpiller protein 1.1T08499SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T77365DI0319Orthostatic hypotension[ICD-11: BA21]P29274ADORA2A
T77365DI0331Parkinsonism[ICD-11: 8A00]P29274ADORA2A
T77365DI0359Radionuclide imaging[ICD-11: N.A.]P29274ADORA2A
T81443DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]O00206TLR4
T81443DI0346Prostate cancer[ICD-11: 2C82]O00206TLR4
T81443DI0375Sepsis[ICD-11: 1G40-1G41]O00206TLR4
T97141DI0127Duodenal ulcer[ICD-11: DA63]Q15746MYLK
T15610DI0012Acute myeloid leukaemia[ICD-11: 2A60]P55786NPEPPS
T15610DI0284Myelodysplastic syndrome[ICD-11: 2A37]P55786NPEPPS
T93653DI0055Bone cancer[ICD-11: 2B5Z]O60911CTSV
T93653DI0087Chronic pain[ICD-11: MG30]O60911CTSV
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T08499DI0087Chronic pain[ICD-11: MG30]Q9UJ67APAF1
T08499DI0167Gout[ICD-11: FA25]Q9UJ67APAF1
T08499DI0339Postoperative inflammation[ICD-11: 1A00-CA43]Q9UJ67APAF1
T08499DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9UJ67APAF1

Copyright © 2025